StockWatch
·

KOVAI MEDICAL CENTER & HOSPITAL LTD.

BSE: 523323

P/L Snapshot

Q2 FY27 · standalone

vs Q1 FY27·vs Q2 FY26
Revenue
480.73
+9.6%+20.7%
Expenditure
376.98
+8.6%+17.6%
Net Profit
76.97
+11.4%+30.8%
OPM %
28.97%
+0.23pp+1.67pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.00134.61269.21403.82538.42Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Price Chart
Reports

KMCH Q2 FY27: standalone PAT +31% YoY to ₹77 Cr, margins expand, just misses ₹79-82 Cr view

hospital · margin expansion · standalone pat growth

ResultsQ2 FY2711 Nov 20263 minPharma & Healthcare

Margin expansion to carry second quarter; capex ramp weighs balance sheet

healthcare · margin expansion · capex

Result previewQ2 FY2710 Nov 20263 minPharma & Healthcare

Kovai Medical Q1 FY27: standalone PAT +21% YoY to ₹69 Cr as margins expand

hospital services · margin expansion · healthcare segment

ResultsQ1 FY2707 Aug 20263 minPharma & Healthcare
Latest
Quarterly Result11 Nov, 6:21 pm

KMCH Q2 FY27: standalone PAT +31% YoY to ₹77 Cr, margins expand, just misses ₹79-82 Cr view

Kovai Medical Center & Hospital's standalone revenue from operations rose to ₹472.63 Cr (+20.9% YoY, +9.6% QoQ) and PAT came in at ₹76.97 Cr (+30.8% YoY, +11.4% QoQ), EPS ₹70.34 against ₹53.79 a year ago. There is no consolidated statement — the company has no subsidiary, associate or JV. Revenue cleared our pre-result expectation of ~₹445 Cr by about 6%, and operating margin at ~28.97% landed inside the ~28-29% band we flagged, but PAT settled just below the ₹79-82 Cr range despite pre-tax profit of ₹103.75 Cr growing a stronger 33.2% YoY — the effective tax rate ticked up to 25.8% this quarter from 24.4% a year ago and 24.5% last quarter, trimming the bottom line relative to the pre-tax beat. The margin expansion itself is real and broad-based: OPM widened to ~28.97% from 27.30% YoY and 28.74% QoQ, and NPM to 16.01% from 14.77% YoY and 15.75% QoQ, even as depreciation (+24.8% YoY to ₹33.42 Cr) and consulting charges to doctors (+15.9% YoY to ₹63.46 Cr) both rose with the hospital's capacity build — consistent with the operating-leverage thesis in our preview, though the filing does not break out occupancy or ARPB, so that specific watch item stays unresolved from disclosed data. The Healthcare segment drove it, with PBIT up 29.2% YoY to ₹113.31 Cr; the smaller Education segment's PBIT fell to ₹5.65 Cr from ₹10.94 Cr sequentially (roughly flat YoY at ₹5.35 Cr), a timing-driven drag rather than a trend. Analyst coverage of KMCH remains thin with no published consensus estimates or price targets found across major platforms, so our own pre-result band is the only available benchmark here — management itself gives no formal forward guidance on record, so this print can only be graded against that bar and against trend, not against a stated company target. Separately, on 27-Oct-2026 the company received a Customs adjudication order on a 1988 machinery-import matter fixing ₹2.11 Cr payable plus an estimated ~₹10 Cr interest; no provision has been booked and management says it is evaluating its response, so this sits as an off-P&L contingent liability rather than a hit to this quarter's reported profit. Capital work-in-progress rose to ₹182.48 Cr from ₹134.96 Cr at FY26-end as the announced ₹120 Cr neuro-sciences block and ₹300 Cr Sulur/children's-hospital expansions progress, while non-current borrowings actually fell to ₹289.57 Cr from ₹317.35 Cr — leverage stayed contained even through the capex ramp. The next quarter is the real test of whether margin expansion holds as more of this capacity comes online, and whether the Customs order turns into a booked provision.

11 Nov 2026, 06:21 pm

Corporate Events

Board MeetingKOVAI
2026
11Nov

Board Meeting

The Board Meeting is scheduled to consider and approve the U…

BSE Filing ↗
Board MeetingKOVAI
2026
26Aug

Board Meeting

To hold the 40th Annual General Meeting and consider the pay…

BSE Filing ↗
DividendKOVAI
2026
19Aug

₹15 / share

BSE Filing ↗
Board MeetingKOVAI
2026
7Aug

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing ↗
Board MeetingKOVAI
2026
6Feb

Board Meeting

Consider and approve the Un-audited Financial Results

BSE Filing ↗
Board MeetingKOVAI
2025
7Nov

Board Meeting

Consider and approve Un-Audited Financial Results

BSE Filing ↗
Board MeetingKOVAI
2025
8Aug

Board Meeting

Consider and approve Un-Audited Financial Results of the Com…

BSE Filing ↗
Board MeetingKOVAI
2025
28May

Board Meeting

Consider and approve Audited Financial Results of the Compan…

BSE Filing ↗
Board MeetingKOVAI
2025
7Feb

Board Meeting

Consider and approve the un-audited financial results

BSE Filing ↗
Board MeetingKOVAI
2024
8Nov

Board Meeting

Consider and approve the Un-Audited Financial Results For Th…

BSE Filing ↗
Board MeetingKOVAI
2024
9Aug

Board Meeting

Consider and approve the Un-Audited Financial Results of the…

BSE Filing ↗
DividendKOVAI
2024
2Aug

₹10 / share

BSE Filing ↗
Board MeetingKOVAI
2024
29May

Board Meeting

Consider and approve Audited Financial Results for the quart…

BSE Filing ↗
Board MeetingKOVAI
2023
10Nov

Board Meeting

Consider and approve Un-audited Financial Results for the qu…

BSE Filing ↗